Purpose: To determine whether the change in the retinal nerve fiber layer (RNFL) thickness in a region of interest (ROI) is a better measure of glaucoma progression than the change in average circumpapillary (cp) RNFL thickness.
G laucoma is a progressive optic neuropathy and a leading cause of blindness worldwide. 1 The goal of therapy is to slow or halt the rate of progression to levels that will be unlikely to affect patients' vision-related quality of life during their lifespan. Therefore, accurately detecting changes over time is a crucial step in glaucoma management.
We recently described a method to measure structural progression in treated glaucoma using a region of interest (ROI) approach. 2 In brief, the ROI analysis focuses on a specific region around the optic nerve head that was abnormal at an earlier visit. After en-face images of the frequency domain optical coherence tomography (fdOCT) scans were aligned according to the position of the blood vessels, circumpapillary (cp) images were derived, the retinal nerve fiber (RNFL) thickness was determined for the baseline and final visit, and the change in width over time (in degrees) of the ROI (ie, the abnormal region) was measured. This ROI method was validated on eyes with disc hemorrhages, which are known to progress more rapidly. [3] [4] [5] When compared with the within-visit variability measurements, the change in the width of the ROI was significant, while the change in average circumpapillary retinal nerve fiber layer (cpRNFL) thickness, commonly used to detect progression in clinical settings and research, 6, 7 was not. 2 Furthermore, while 94% of the ROIs increased in width, only 68% of the eyes showed a decrease in average cpRNFL thickness. These findings suggest that the ROI approach may be more sensitive for detecting progression than the more conventional global indices. However, the sample was small and restricted to eyes with disc hemorrhages.
The purpose here was to extend the ROI approach to eyes with early glaucomatous damage. Specifically, we examined the ROI change in eyes with early or suspected glaucomatous damage over time and compared it to the average cpRNFL change during the same time period. We hypothesized that for detecting progression, the ROI approach would be superior to using average cpRNFL thickness.
METHODS
This prospective study was approved by the Institutional Review Boards of Columbia University and the New York Eye and Ear Infirmary of Mount Sinai and followed the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. Written informed consent was obtained from all eligible patients.
In total, 60 eyes of 60 patients (age, 61.7 ± 12.7 y) were selected from a larger group of eyes in our early glaucoma database (EGD). These 60 eyes had fdOCT disc scans (3D-OCT2000, Topcon) on at least 2 visits that were free of eye movement and other artifacts. The EGD includes eyes with suspicious or abnormal discs and 24-2 visual field (VF) mean deviation values better than À6 dB (SITA-Standard, Humphrey Field Analyzer; Carl Zeiss Meditec Inc., Dublin, CA). Abnormal discs were defined as described by the American Academy of Ophthalmology Preferred Practice Pattern guidelines 8 and included the following: focal or diffuse neuroretinal rim thinning, focal or diffuse RNFL loss, or an intereye vertical cup-to-disc ratio asymmetry >0.2 not explained by differences in disc size. All EGD eyes had a refractive error between ± 6 D, were free of other disease processes that could affect the VF, and did not have clinically significant cataracts based upon the Lens Opacities Classification System (III). For the 60 eyes, the time between the baseline scan and final scan averaged 3.2 ± 1.8 years (range, 0.5 to 7.0 y), and their average 24-2 mean deviation on the first visit was À1.67. Figure 1 illustrates the ROI method on 1 example eye. On each OCT scan, the RNFL borders were defined by commercial software and the segmentation was corrected by hand, if necessary. En-face images of the disc cube scans on the baseline ( (Fig. 1C ) was generated for both visits. 2 In Figure 1C , these cpRNFL thickness profiles are shown for the baseline visit (dashed blue line) and the final visit (black solid line) for the example eye.
An ROI was defined as the portion of the cpRNFL thickness profile in the baseline scan that extended below the 1% confidence interval (CI) (red region in Fig. 1C ) of the manufacturer's normative database for at least 5 degrees. Only the temporal half of the disc (between À90 and 90 degrees for a right eye orientation) was included to correspond to the major portion of the 24-2 VF test locations.
Because the goal was to evaluate progression, an ROI on the final scan was measured only if there was an ROI present on the baseline scan. Also, if an eye had >1 ROI, each was recorded as a separate defect. Adjustments for using >1 ROI per eye and both eyes of the same patient are described below. Furthermore, to avoid splitting a continuous defect into 2, if 2 defects fell within 12 degrees of each other, they were recorded as the same defect by using the starting point of the first ROI and the ending point of the final ROI. In addition to the width of each ROI, the average cpRNFL thickness was also calculated for the 60 eyes on each visit by taking the average of the values in the cpRNFL thickness profile in Figure 1C .
Statistical Analysis
The ROI width and average cpRNFL thickness progression were evaluated using a trend-based approach and multilevel mixed-effects models. These models included 3 levels: patient, eye, and ROI. This statistical method involves both random intercepts and random slopes associated with these levels of observations. Hence, it takes into account the correlation between ROIs within the same eye, when they existed, as well as intereye correlations. In addition, mixed-effects models allow the analysis of repeated measurements of individuals over time, despite the correlation of errors between timepoints, for which ordinary least squares models are not recommended. 9 Two models were built using the following dependent variables: (i) ROI width and (ii) average cpRNFL thickness. Time was set as independent variable, whereas random effects related to the subject (ie, each eye nested within each subject, and each ROI nested within each eye) were included to measure changes over time. The coefficient associated with the variable "Time" describes the slope (or rate of change) per year of the dependent variables and its P-value reflects whether this change was significant compared with a flat slope (ie, no progression). Statistical significance was defined at P < 5%. Statistical analyses were carried out with commercially available software (STATA, version 14; StataCorp LP, College Station, TX).
RESULTS
In total, 26 of the 60 eyes had ROIs. Figure 2 shows the location and extent of the ROIs for each of these eyes. Seven of these 26 eyes had 2 ROIs, for a total of 33 ROIs.
The horizontal bars in Figure 2 indicate the extent of the ROIs on the baseline (blue) and final (black) visit. In total, 25 of the 33 ROIs included part of the region associated with the macula (pale orange, between À45 to 69 degrees) and 17 of these included at least part of the macular vulnerability zone (blue, 38 to 69 degrees), the region of the disc most often associated with arcuate damage of the macula. 10, 11 For the ROIs, 85% (28/33) showed an increase in width between visits, with 88% (23/26) of the eyes showing at least 1 ROI that increased. The median ROI value on the first visit was 31.5 degrees (range, 5.1 to 168.9 degrees), and the median ROI value on the second visit was 25.1 degrees (range, 4.7 to 164.7 degrees). The mean ROI change between visits was 6.35 degrees and the median was 4.9 degrees (interquartiles, Q1: 1.03, Q3: 10.5 degrees).
In comparison, only 58% (35/60) of the average cpRNFL thickness measurements showed a decrease between visits. The median cpRNFL value on the first visit was 91.9 mm (range, 49.8 to 114.7 mm), and the median cpRNFL value on the second visit was 89.9 mm (range, 48.8 to 115.1 mm). The mean cpRNFL change between visits was À0.18 mm and the median was À 0.7 mm (Q1: À2.7 mm, Q3: 2.7 mm). In addition, there was no relationship between change in average cpRNFL thickness and change in ROI (R 2 = 0.003, P = 0.78).
To overcome the fact that not all eyes had an ROI, we compared the ROI and cpRNFL measurements for the subset of eyes with ROIs (26 eyes, 33 ROIs). For eyes with multiple ROIs, only the largest ROI based on the initial visit was considered. For this subset, 77% (20/26) of the eyes showed positive ROI change between visits (ie, progression), whereas only 35% (9/26) showed cpRNFL thinning between visits.
The results of the multilevel mixed-effects linear models are shown in Table 1 . The ROIs were classified as being in the macula or not (ie, projecting to the central 8 degrees around the fovea). Overall ROI change and macular ROI change between visits had statistically significant P values (1.4 degrees increase/year, P = 0.015 and 1.69 degrees increase/year, P = 0.011, respectively), whereas cpRNFL change did not (P = 0.878). The residual plots did not indicate any deviations from normality or heteroscedasticity, supporting the assumptions of the models.
DISCUSSION
Global metrics such as average cpRNFL thickness are commonly used to track progression in patients with early or suspected glaucoma. In this study, we tested the hypothesis that a ROI approach would be a more robust method for evaluating the progression of local, glaucomatous damage. Our results support this hypothesis in eyes with early glaucoma. The ROI change over time was significant, but the average cpRNFL thickness was not. This is not to say that cpRNFL thickness should not be used in addition to a ROI approach. It is plausible that the average cpRNFL thickness may pick up global decreases in RNFL due to widespread thinning of the RNFL over time. Progression of the ROI may be overlooked using cpRNFL thickness due to spatial averaging, which inherently reduces sensitivity to detect local change.
Various alternative strategies to detect progression of glaucomatous damage have been proposed. Of the studies that investigate changes in OCT cpRNFL thickness measurements, some 12, 13 favor average cpRNFL thickness change, whereas others 14,15 emphasize quadrant or clock hour analyses. In addition, recent reviews 15, 16 encourage analyzing the RNFL thickness maps of the entire region around the disc. Our approach also measures RNFL thickness from optic disc scans, but we specifically focus on the damaged region. In particular, our ROI method is part of a general approach 17 that examines OCT scans in a manner similar to that used by a radiologist when analyzing an magnetic resonance imaging or computed tomographic scan.
Limitations
The ROI approach was designed for identifying changes in local defects over time. Consequently, it may not be suitable for patients with early diffuse damage [18] [19] [20] ; advanced glaucoma, where the damage is often widespread 21 ; or eyes with extensive peripapillary atrophy (in which cpRNFL segmentation errors are common). In contrast, in many eyes with advanced glaucoma, there is a region of relatively healthy cpRNFL tissue, often associated with the papillomacular bundle. In these cases, the ROI method could be modified to track the preserved region as opposed to the affected region. That is, we suggest reversing our present definition of an ROI to measure the portion of the cp scan that exceeds the 99% (or 95%) CI for healthy norms.
In addition, in this study, we defined progression based on an increase in width of a localized cpRNFL defect, which, unlike a thickness measure, does not have a clear floor effect. Although expansion of an existing defect is the most common pattern of progression, 22 there are other types of progression, such as the deepening of a defect and the development of a new defect at a different location. Thus, there may have been eyes in our study that exemplified progression in ways that we did not consider.
Moreover, although we showed a higher sensitivity of the ROI approach to detect progression, we did not investigate its specificity in the present study. This would require either (i) following healthy subjects over a similar follow-up time (3.2 y) or (ii) following glaucoma patients with short test-retest intervals (eg, days or weeks). The former is not plausible as healthy eyes do not have a ROI. The latter would then be ideal, although we did not collect data using that protocol. Nonetheless, when looking at the short-term variability of our dataset (ie, test-retest within the same day) the standardized difference between ROI width measurements on the same day was negligible (À0.02; 95% CI, À 0.55 to 0.50; P = 0.927), and the same was true 
